US 8273797
Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde
granted A61KA61K31/145A61K31/15
Quick answer
US patent 8273797 (Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/145, A61K31/15, A61K31/245, A61K31/277